www.fdanews.com/articles/63209-pharma-blog-watch
Pharma Blog Watch
October 10, 2006
The
Safety of Natrecor (Drug Injury Watch)
In his blog, Tom Lamb discusses an article in the journal Pharmacotherapy
about "the need to resolve the safety issues surrounding the heart failure
drug Natrecor (nesiritide)." Recent studies of the drug, which is made
by Johnson & Johnson unit Scios, found that "Natrecor is associated
with a significant increased risk of death."
"Until the safety issues are resolved, as advised by Dorsch and Rodgers in their article 'Nesiritide: harmful or harmless?', it seems that the use of Natrecor should be limited," he writes.